PATH VACCINE SOLUTIONS: Form 990, tax year 2010

View the entire original 990 at ProPublica ↗

Organization
PATH VACCINE SOLUTIONS (EIN 83-0431851)
Tax period
2010-01-01 to 2010-12-31
Filed
2011-10-13
IRS object ID
201112869349300311
Schema version
2010v3.4
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2011-10-13T10:44:00-05:00Timestamp
Tax Period End Date2010-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1GELMAN ROSENBERG & FREEDMANBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line14550 MONTGOMERY AVE SUITE 650 NORTHAddressLine1
CityBETHESDACity
StateMDState
ZIP Code208142930ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2010-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN830431851EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1PATH VACCINE SOLUTIONSBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlPATHNameControl
Phone2062853500Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98121ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameERIC WALKERName
TitleBOARD CHAIRTitle
Phone2062853500Phone
Date Signed2011-10-13DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
Phone3019519090Phone
FieldValueIRS element (for citing)
Tax Year2010TaxYear
Build TS2016-03-07 17:11:31ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonCHRISTOPHER J ELIASNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98121ZIPCode
FieldValueIRS element (for citing)
Gross Receipts32789331GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.PATH.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation2006YearFormation
State Legal DomicileWAStateLegalDomicile
Activity Or Mission DescriptionTHE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE IN COUNTRIES THAT NEED THEM MOST. FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.ActivityOrMissionDescription
Nbr Voting Members Governing Body7NbrVotingMembersGoverningBody
Nbr Independent Voting Members3NbrIndependentVotingMembers
Total Nbr Employees0TotalNbrEmployees
Total Nbr Volunteers0TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year31083199ContributionsGrantsPriorYear
Contributions Grants Current Year32724826ContributionsGrantsCurrentYear
Program Service Revenue Prior Year1500ProgramServiceRevenuePriorYear
Program Service Revenue CY3500ProgramServiceRevenueCY
Investment Income Prior Year174229InvestmentIncomePriorYear
Investment Income Current Year53857InvestmentIncomeCurrentYear
Other Revenue Prior Year22681OtherRevenuePriorYear
Other Revenue Current Year7148OtherRevenueCurrentYear
Total Revenue Prior Year31281609TotalRevenuePriorYear
Total Revenue Current Year32789331TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year31772234GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY30660682GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year0SalariesEtcPriorYear
Salaries Etc Current Year0SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year0TotalFundrsngExpCurrentYear
Other Expense Prior Year3230106OtherExpensePriorYear
Other Expenses Current Year5260313OtherExpensesCurrentYear
Total Expenses Prior Year35002340TotalExpensesPriorYear
Total Expenses Current Year35920995TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-3720731RevenuesLessExpensesPriorYear
Revenues Less Expenses CY-3131664RevenuesLessExpensesCY
Total Assets BOY152797602TotalAssetsBOY
Total Assets EOY151102797TotalAssetsEOY
Total Liabilities BOY3346736TotalLiabilitiesBOY
Total Liabilities EOY4781234TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY149450866NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY146321563NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionPVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN NONCLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-INCOME COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT WILL HELP ENSURE THAT THE PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense35920995Expense
Grants30660682Grants
Revenue10648Revenue
DescriptionPVS WORKS TO PREVENT DEATHS FROM PNEUMONIA, INFLUENZA, AND DIARRHEA AMONG CHILDREN AROUND THE WORLD BY ACCELERATING VACCINE DEVELOPMENT. IN PARTNERSHIP WITH MULTIPLE PUBLIC AND PRIVATE GROUPS, PVS DEVELOPS SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES AGAINST PNEUMOCOCCAL DISEASE, INFLUENZA, ROTAVIRUS, SHIGELLA, AND ENTEROTOXIGENIC ESCHERICHIA COLI. IN 2010, PVS ADVANCED RESEARCH AND DEVELOPMENT OF A NUMBER OF PROMISING PNEUMOCOCCAL VACCINE CANDIDATES AND RELATED TECHNOLOGIES. THIS WORK COVERED MULTIPLE STAGES IN THE DEVELOPMENT PROCESS, FROM PRELIMINARY RESEARCH TO PRECLINICAL DEVELOPMENT TO CLINICAL TRIALS FOR SEVERAL CANDIDATES. FOR EXAMPLE, WE SUPPORTED THE ADVANCEMENT OF AN INACTIVATED WHOLE CELL VACCINE THAT HAS SHOWN PROMISE IN PRECLINICAL TESTING THROUGH A SUCCESSFUL PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE US FOOD AND DRUG ADMINISTRATION. AND WE PREPARED TO LAUNCH A TWO-STAGE PHASE 2 CLINICAL TRIAL IN THE GAMBIA OF A VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE. OUR PARTNERS INCLUDED ACADEMIC GROUPS (SUCH AS THE UNIVERSITY OF ADELAIDE, BUTANTAN INSTITUTE IN BRAZIL, UNIVERSITY OF GLASGOW, AND THE LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE), INDUSTRY PARTNERS (INCLUDING CHINA NATIONAL BIOTEC GROUP'S CHENGDU INSTITUTE OF BIOLOGICAL PRODUCTS, GENOCEA BIOSCIENCES, GLAXOSMITHKLINE BIOLOGICALS, INTERCELL AG, MUCOSIS BV, AND THE SERUM INSTITUTE OF INDIA LTD.), AND HEALTH CARE INSTITUTIONS (SUCH AS CHILDREN'S HOSPITAL BOSTON). PVS ALSO WORKED DURING 2010 TO ADVANCE DEVELOPMENT OF PROMISING NEW INFLUENZA VACCINES, FOCUSING ON NOVEL TECHNOLOGIES THAT CAN BE ACCESSIBLE, AFFORDABLE, AND AVAILABLE TO PEOPLE IN LOW-RESOURCE SETTINGS DURING INFLUENZA OUTBREAKS. HIGHLIGHTS INCLUDED ADVANCING PRECLINICAL DEVELOPMENT OF SEVERAL AVIAN LIVE ATTENUATED INFLUENZA VACCINE CANDIDATES, CONDUCTING A LANDSCAPE ANALYSIS FOR INTRANASAL DELIVERY DEVICES TO BE USED WITH THOSE VACCINE CANDIDATES, AND ENTERING INTO NEW PARTNERSHIPS TO INITIATE RESEARCH ON INFLUENZA VACCINES THAT CAN ELICIT BROAD COVERAGE ACROSS INFLUENZA STRAINS. OUR PARTNERS INCLUDED THE INSTITUTE OF EXPERIMENTAL MEDICINE IN RUSSIA, MEDICAGO INC., LENTIGEN, THE UNIVERSITY OF PITTSBURGH, AND THE INFECTIOUS DISEASE RESEARCH INSTITUTE OF SEATTLE.INFECTION WITH ROTAVIRUS IS A MAJOR CAUSE OF SEVERE DIARRHEA AND DEATH AMONG YOUNG CHILDREN IN LOW-INCOME COUNTRIES. PVS AIMS TO ACCELERATE INTRODUCTION OF SAFE, AFFORDABLE, AND EFFECTIVE ROTAVIRUS VACCINES IN THE DEVELOPING WORLD BY PROVIDING TECHNICAL AND FINANCIAL SUPPORT TO EMERGING-COUNTRY MANUFACTURERS. HIGHLIGHTS DURING 2010 INCLUDED WORKING WITH BHARAT BIOTECH INTERNATIONAL IN INDIA TO SUPPORT THE LATE-STAGE DEVELOPMENT OF A PROMISING VACCINE CANDIDATE AND PREPARE FOR PHASE 3 EFFICACY CLINICAL TRIALS; PARTNERING WITH THE SERUM INSTITUTE OF INDIA LTD. TO PREPARE FOR PHASE 3 CLINICAL TRIALS OF ANOTHER TYPE OF ROTAVIRUS VACCINE; AND PROVIDING A SHARED TECHNOLOGY PLATFORM THAT ALLOWS MANUFACTURERS OF NEW ROTAVIRUS VACCINES TO ACCESS A HOST OF NEEDED TECHNOLOGIES, TRAINING, AND TECHNICAL SUPPORT.PVS ALSO ADVANCES RESEARCH AND DEVELOPMENT OF VACCINES AGAINST THE TWO LEADING BACTERIAL CAUSES OF DIARRHEA, SHIGELLA AND ENTEROTOXIGENIC ESCHERICHIA COLI. MUCH OF THIS WORK IS DONE THROUGH PARTNERSHIPS WITH PUBLIC- AND PRIVATE-SECTOR ORGANIZATIONS. KEY ACTIVITIES IN 2010 INCLUDED SIGNING SEVEN NEW PARTNERSHIP AGREEMENTS FOR RESEARCH, DEVELOPMENT, AND TESTING OF VACCINE CANDIDATES AND RELATED TECHNOLOGY; COMPLETING A PHASE 2B CHALLENGE STUDY OF ONE VACCINE CANDIDATE AND HELPING TO SUPPORT THE LAUNCH OF PHASE 1 TRIALS OF TWO OTHER VACCINE CANDIDATES; AND FUNDING AND HOSTING VACCINE WORKSHOPS ON DIARRHEAL DISEASE IN VIETNAM AND THE USE OF ORAL VACCINES IN INFANTS. OUR PARTNERS INCLUDED THE INTERNATIONAL VACCINE INITIATIVE, OKLAHOMA STATE UNIVERSITY, THE US NAVAL MEDICAL RESEARCH CENTER, MUCOSIS B.V., THE UNIVERSITY OF MARYLAND, BALTIMORE, AND THE WALTER REED ARMY INSTITUTE OF RESEARCH.Description
Total Program Service Expense35920995TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities0LobbyingActivities
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip0ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities0ReportOtherLiabilities
Report Fin48 Footnote0ReportFin48Footnote
Independent Audit Financial Stmt0IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt1ConsolidatedAuditFinancialStmt
School0School
Foreign Office1ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations1MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With10960NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Number Of Employees0NumberOfEmployees
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions0QuidProQuoContributions
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members7NbrVotingGoverningBodyMembers
Number Independent Voting Members3NumberIndependentVotingMembers
Family Or Business Relationship0FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members0ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO0CompensationProcessCEO
Compensation Process Other0CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledWAStatesWhereCopyOfReturnIsFiled
Other WebsiteXOtherWebsite
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1MARLOW KEE CHIEF FINANCIAL OFFICERBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number2062853500TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98121ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (8 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensation
CHRISTOPHER J ELIAS
CHAIR1.00XX051689339394
JACQUELINE D SHERRIS
VICE CHAIR1.00XX023794428352
ERIC G WALKER
TREASURER1.00XX022409735303
DAN LASTER
DIRECTOR1.00X020832226579
N REGINA RABINOVICH
DIRECTOR1.00X000
DOUGLAS HOLTZMAN
DIRECTOR1.00X000
TOM BREWER
DIRECTOR1.00X000
DAVID ALLI
BOARD SECRETARY1.00X013899124912
FieldValueIRS element (for citing)
Total Reportable Comp From Org0TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs1326247TotalReportableCompFrmRltdOrgs
Total Other Compensation154540TotalOtherCompensation
Number Individuals GT100 K0NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources
Number Of Contractors GT100 K0NumberOfContractorsGT100K
All Other Contributions32724826AllOtherContributions
Total Contributions32724826TotalContributions

Program Service Revenue ProgramServiceRevenue

FieldValueIRS element (for citing)
DescriptionHONORARIADescription
Business Code900099BusinessCode
Total Revenue Column3500TotalRevenueColumn
Related Or Exempt Function Income3500RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue3500TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column53857TotalRevenueColumn
Exclusion$53,857ExclusionAmount

Other Revenue Misc OtherRevenueMisc

FieldValueIRS element (for citing)
DescriptionOTHER REIMBURSEMENTDescription
Business Code900099BusinessCode
Total Revenue Column7148TotalRevenueColumn
Related Or Exempt Function Income7148RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Other Revenue7148TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column32789331TotalRevenueColumn
Related Or Exempt Function Income10648RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$53,857ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total16898669Total
Program Services16898669ProgramServices

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total13762013Total
Program Services13762013ProgramServices

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total60024Total
Program Services60024ProgramServices

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total1010Total
Program Services1010ProgramServices

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total7837Total
Program Services7837ProgramServices

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total378733Total
Program Services378733ProgramServices

Advertising Advertising

FieldValueIRS element (for citing)
Total15491Total
Program Services15491ProgramServices

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total244341Total
Program Services244341ProgramServices

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total4769Total
Program Services4769ProgramServices

Travel Travel

FieldValueIRS element (for citing)
Total1358878Total
Program Services1358878ProgramServices

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total148536Total
Program Services148536ProgramServices

Insurance Insurance

FieldValueIRS element (for citing)
Total12433Total
Program Services12433ProgramServices

Other Expenses OtherExpenses (5 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServices
SUBCONTRACTS28762742876274
LAB SUPPLIES6719667196
TAXES5511855118
EQUIPMENT R&M & PROCURE2723727237
PROF. DUES/MEMBERSHIPS25822582

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total-146Total
Program Services-146ProgramServices

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total35920995Total
Program Services35920995ProgramServices
Management And General0ManagementAndGeneral
Fundraising0Fundraising
FieldValueIRS element (for citing)
Joint CostsXJointCosts

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY49427914BOY
EOY10065380EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY103363592BOY
EOY80022019EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY6096BOY
EOY78013EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
EOY60937385EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY152797602BOY
EOY151102797EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY3346736BOY
EOY4781234EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY3346736BOY
EOY4781234EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY149450866BOY
EOY146321563EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY149450866BOY
EOY146321563EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY152797602BOY
EOY151102797EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses-3131664ReconcilationRevenueExpenses
Reconcilation Other Changes2361ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement ConsolidatedXFinancialStatementConsolidated
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3XSupportingOrganization509a3
Supporting Org509a3 Type1XSupportingOrg509a3Type1
Certification CheckboxXCertificationCheckbox
Contrib By Controlling Individual0ContribByControllingIndividual
Contribution By Related Party0ContributionByRelatedParty
Contrib By35 Controlled Entity0ContribBy35ControlledEntity

Supported Org Information SupportedOrgInformation

Name Name

FieldValueIRS element (for citing)
Business Name Line1PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTHBusinessNameLine1
FieldValueIRS element (for citing)
EIN911157127EIN
Type Of OrganizationBOX 7TypeOfOrganization
Listed In Governing Doc1ListedInGoverningDoc
Amount$35,920,995Amount
FieldValueIRS element (for citing)
Total Number Of Supported Orgs1TotalNumberOfSupportedOrgs
Sum Of Amounts35920995SumOfAmounts

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained1GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (15 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EAST ASIA AND THE PACIFIC05PROGRAM SRVCSVACCINES AND IMMUNIZATIONS259302
EAST ASIA AND THE PACIFICGRANTS1298564
EUROPE03PROGRAM SRVCSVACCINES AND IMMUNIZATIONS780323
EUROPEGRANTS4420999
MIDDLE EAST00PROGRAM SRVCSVACCINES AND IMMUNIZATIONS210
NORTH AMERICA00PROGRAM SRVCSVACCINES AND IMMUNIZATIONS43489
NORTH AMERICAGRANTS300000
RUSSIA AND THE NEWLY INDEPENDENT STATESPROGRAM SRVCSVACCINES AND IMMUNIZATIONS5410
RUSSIA AND THE NEWLY INDEPENDENT STATESGRANTS716500
SOUTH AMERICAPROGRAM SRVCSVACCINES AND IMMUNIZATIONS25
SOUTH AMERICAGRANTS440595
SOUTH ASIA3PROGRAM SRVCSVACCINES AND IMMUNIZATIONS425475
SOUTH ASIAGRANTS5184007
SUB-SAHARAN AFRICA1PROGRAM SRVCSVACCINES AND IMMUNIZATIONS155714
SUB-SAHARAN AFRICAGRANTS1401348
FieldValueIRS element (for citing)
Subtotal Number Of Employees8SubtotalNumberOfEmployees
Cont Number Of Employees4ContNumberOfEmployees
Total Number Of Employees12TotalNumberOfEmployees
Subtotal Amount Spent7108297SubtotalAmountSpent
Cont Amount Spent8323664ContAmountSpent
Total Amount Spent15431961TotalAmountSpent
No Recipient Over5 KXNoRecipientOver5K

Grants To Orgs Outside US GrantsToOrgsOutsideUS (29 entries)

RegionRegionPurpose Of GrantPurposeOfGrantAmount Of Cash GrantAmountOfCashGrant
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS21084
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS21000
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS383460
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS60000
SOUTH ASIAVACCINES AND IMMUNIZATIONS196244
EUROPEVACCINES AND IMMUNIZATIONS22574
EUROPEVACCINES AND IMMUNIZATIONS427920
SOUTH AMERICAVACCINES AND IMMUNIZATIONS440595
EUROPEVACCINES AND IMMUNIZATIONS1434569
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS650000
SOUTH ASIAVACCINES AND IMMUNIZATIONS60000
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS13561
NORTH AMERICAVACCINES AND IMMUNIZATIONS300000
SUB-SAHARAN AFRICAVACCINES AND IMMUNIZATIONS960664
EUROPEVACCINES AND IMMUNIZATIONS338835
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS9036
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS12371
EUROPEVACCINES AND IMMUNIZATIONS37500
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS28052
RUSSIA AND THE NEWLY INDEPENDENT STATESVACCINES AND IMMUNIZATIONS716500
SOUTH ASIAVACCINES AND IMMUNIZATIONS3500000
SOUTH ASIAVACCINES AND IMMUNIZATIONS12391
SOUTH ASIAVACCINES AND IMMUNIZATIONS1415372
EUROPEVACCINES AND IMMUNIZATIONS800000
SUB-SAHARAN AFRICAVACCINES AND IMMUNIZATIONS440684
EUROPEVACCINES AND IMMUNIZATIONS65181
EAST ASIA & THE PACIFICVACCINES AND IMMUNIZATIONS100000
EUROPEVACCINES AND IMMUNIZATIONS394421
EUROPEVACCINES AND IMMUNIZATIONS900000
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs19TotalNumberOf501c3Orgs
Total Number Of Other Orgs10TotalNumberOfOtherOrgs
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:Identifier
ExplanationSCHEDULE F, PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES.Explanation

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (21 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrantAddress Line2AddressUS/AddressLine2
ALBERT B SABIN INSTITUTE INC
2000 PENNSYLVANIA AVENUE NWWASHINGTONDC20006061389829501(C)(3)16000VACCINES AND IMMUNIZATIONS
BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY
340 PANAMA STSTANFORDCA94305941156365501(C)(3)15446VACCINES AND IMMUNIZATIONS
CHILDREN'S HOSPITAL BOSTON
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)75000VACCINES AND IMMUNIZATIONS
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229310833936501(C)(3)23533VACCINES AND IMMUNIZATIONS
EMMES CORPORATION THE
401 NORTH WASHINGTON STREET SUITEROCKVILLEMD20850541058268N/A95686VACCINES AND IMMUNIZATIONS700
FOOD & DRUG ADMINISTRATION (FDA)
DHHS/FDA/CDRH/OST/DMMSBETHESDAMD20892530196965GOVERNMENT380000VACCINES AND IMMUNIZATIONS
GENOCEA BIOSCIENCES INC
161 FIRST STREETCAMBRIDGEMA02139510596811N/A638804VACCINES AND IMMUNIZATIONS
INC RESEARCH INC
4700 FALLS OF NEUSE SUITE 400RALEIGHNC27609330723120N/A9143VACCINES AND IMMUNIZATIONS
INFECTIOUS DISEASE RESEARCH INSTITUTE (IDRI)
1124 COLUMBIA STREET SUITE 400SEATTLEWA98104911608978501(C)(3)500000VACCINES AND IMMUNIZATIONS
INTEGRESS MEETINGS AND EVENTS
2 RAVINIA DRIVE SUITE 605ATLANTAGA30346582526963N/A40000VACCINES AND IMMUNIZATIONS
LENTIGEN CORPORATION
910 CLOPPER ROAD SUITE 200GAITHERSBURGMD20878861131845N/A1467612VACCINES AND IMMUNIZATIONS
NEUGENESIS CORPORATION
863 MITTEN ROAD SUITE CBURLINGAMECA94010990299143N/A186571VACCINES AND IMMUNIZATIONS
PITTSBURGH UNIVERSITY OF
OFFICE OF RESEARCH 123 UNIVERSITYPITTSBURGHPA15213250965591501(C)(3)400000VACCINES AND IMMUNIZATIONSPLACE LOWER LOBBY
PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH
2201 WESTLAKE AVENUE SUITE 200SEATTLEWA98121911157127501(C)(3)10280497VACCINES AND IMMUNIZATIONS
PURDUE UNIVERSITY
610 PURDUE MALLWEST LAFAYETTEIN47907356002041501(C)(3)43390VACCINES AND IMMUNIZATIONS
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL35294636005396501(C)(3)310000VACCINES AND IMMUNIZATIONS
THE JOHNS HOPKINS UNIVERSITY
APPLIED PHYSICS LABORATORY JOHNSLAURELMD20707520595110501(C)(3)250000VACCINES AND IMMUNIZATIONSHOPKINS ROAD
UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC
2385 IRVING HILL ROADLAWRENCEKS66045480680117501(C)(3)165000VACCINES AND IMMUNIZATIONS
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428BALTIMOREMD21203526002033501(C)(3)406665VACCINES AND IMMUNIZATIONS
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER THE
1000 SL YOUNGOKLAHOMA CITYOK73104736017987501(C)(3)84661VACCINES AND IMMUNIZATIONS
WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR)
503 ROBERT GRANT AVENUESILVER SPRINGMD10910520664528GOVERNMENT1507444VACCINES AND IMMUNIZATIONS
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants15TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations6TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (5 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
CHRISTOPHER J ELIAS
039944601171470300028828010566055628700
JACQUELINE D SHERRIS
023764400030002656901783026629600
ERIC G WALKER
0223636000461024545010758025940000
DAN LASTER
0208322000001666609913023490100
DAVID ALLI
0138991000001667908233016390300

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (5 entries)

IdentifierIdentifierExplanationExplanationReturn ReferenceReturnReference
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY ACCOUNTING SERVICES STAFF. THE FORM 990 WAS REVIEWED BY SENIOR MANAGEMENT. A COPY OF THE DRAFT FORM 990 WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE PRESIDENT AND CEO SIGNED THE RETURN.
BOARD MEMBERS, PVS MANAGEMENT, AND ALL STAFF ABOVE A DESIGNATED LEVEL MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. EACH YEAR AT THE ANNUAL MEETING, THE GENERAL COUNSEL INFORMS BOARD MEMBERS OF THE REQUIREMENT TO DISCLOSE ANY CONFLICT OF INTEREST. EACH BOARD MEMBER COMPLETES AND SIGNS A CONFLICT FORM ANNUALLY.FORM 990, PART VI, SECTION B, LINE 12C
PVS'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE UPON REQUEST.FORM 990, PART VI, SECTION C, LINE 19
CHANGES IN NET ASSETS OR FUND BALANCES:NET UNREALIZED GAINS ON INVESTMENTS: 2,361.FORM 990, PART XI, LINE 5:
CHRISTOPHER J. ELIAS, CHAIR, DEVOTES 40 HOURS PER WEEK TO THE PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH), AS ITS PRESIDENT AND CEO. JACQUELINE D. SHERRIS, VICE CHAIR, DEVOTES 40 HOURS PER WEEK TO PATH AS ITS VICE PRESIDENT OF GLOBAL PROGRAMS. ERIC G. WALKER, TREASURER, DEVOTES 40 HOURS PER WEEK TO PATH AS ITS VICE PRESIDENT OF CORPORATE SERVICES. DAN LASTER, DIRECTOR, DEVOTES 40 HOURS PER WEEK TO PATH AS ITS GENERAL COUNSEL. DAVID ALLI, BOARD SECRETARY, DEVOTES 40 HOURS PER WEEK TO PATH AS ITS DIRECTOR OF ADMINISTRATION AND FINANCE FOR VACCINE DEVELOPMENT.FORM 990, PART VII, SECTION A, COLUMN (B):

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII

Name Of Disregarded Entity NameOfDisregardedEntity

FieldValueIRS element (for citing)
Business Name Line1PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTHBusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98109ZIPCode
FieldValueIRS element (for citing)
EIN911157127EIN
Primary ActivitiesGLOBAL HEALTHPrimaryActivities
Legal Domicile StateWALegalDomicileState
Exempt Code Section501(C)(3)ExemptCodeSection
Public Charity StatusBOX 7PublicCharityStatus
Controlled Org0ControlledOrg
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties0ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org0GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org0LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs0RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs0PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs0PerformOfServicesByOtherOrgs
Sharing Of Facilities0SharingOfFacilities
Sharing Of Paid Employees0SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrg
Other Transfer To Other Org0OtherTransferToOtherOrg
Other Transfer From Other Org0OtherTransferFromOtherOrg

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.